Julia Benckert
Mitte, BE, Germany
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 23 publications
Second-line tacrolimus and mycophenolate mofetil in difficult-to-treat autoimmune hepatitis.
Journal: Hepatology communications
Published: September 25, 2025
Profiling of the tumor-associated microbiome in patients with hepatocellular carcinoma.
Journal: Gut pathogens
Published: June 04, 2025
Characteristics of patients with epithelioid hemangioendothelioma (EHE): a retrospective analysis of the Charité- Universitätsmedizin Berlin.
Journal: Journal of cancer research and clinical oncology
Published: May 16, 2025
Bone Mineral Density Does Not Predict Overall Survival in Patients with Advanced Hepatocellular Carcinoma: A Subanalysis of the SORAMIC Trial.
Journal: Digestive diseases (Basel, Switzerland)
Published: April 18, 2025
Extrahepatic Replication and Genomic Signatures of the Hepatitis E Virus in the Kidney.
Journal: Liver international : official journal of the International Association for the Study of the Liver
Published: June 08, 2024
Skeletal muscle quality predicts overall survival in advanced liver hepatocellular carcinoma treated with SIRT and sorafenib: A subanalysis of the SORAMIC trial.
Journal: United European gastroenterology journal
Published: April 16, 2024
Corrigendum: Sorafenib increases cytochrome P450 lipid metabolites in patient with hepatocellular carcinoma.
Journal: Frontiers in pharmacology
Published: December 12, 2023
Sorafenib increases cytochrome P450 lipid metabolites in patient with hepatocellular carcinoma.
Journal: Frontiers in pharmacology
Published: December 14, 2022
Prognostic role of radiomics-based body composition analysis for the 1-year survival for hepatocellular carcinoma patients.
Journal: Journal of cachexia, sarcopenia and muscle
Published: October 21, 2022
Impact of body composition in advanced hepatocellular carcinoma: A subanalysis of the SORAMIC trial.
Impact of body composition in advanced hepatocellular carcinoma: A subanalysis of the SORAMIC trial.
Journal: Hepatology communications
Published: October 01, 2022
Transarterial Yttrium-90 Radioembolization in Intrahepatic Cholangiocarcinoma Patients: Outcome Assessment Applying a Prognostic Score.
Journal: Cancers
Published: September 16, 2022
Addition of Y-90 radioembolization increases tumor response and local disease control in hepatocellular carcinoma patients receiving sorafenib.
Journal: European journal of nuclear medicine and molecular imaging
Published: May 23, 2022
Last Updated: 09/26/2026